Robert J. Palmisano

This profile gathers the share dealings of Robert J. Palmisano across 2 companies, led by RxSight, Inc. and AEON Biopharma, Inc. We count 8 filings; the first trade dates from 3 August 2021 and the latest from 17 June 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 22 June 2026: a share grant, in AEON Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.